Jones Financial Companies
ATOS icon

Jones Financial Companies’s Atossa Therapeutics ATOS Stock Holding History

Jones Financial Companies’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.88K Hold
2,061
– – ﹤0.01% 4212
2026
Q1 		$9.73K Buy
2,061
+2,014
+4,285% +$12.8K ﹤0.01% 3589
2025
Q4 		$413 Hold
47
– – ﹤0.01% 4191
2025
Q3 		$601 Hold
47
– – ﹤0.01% 4003
2025
Q2 		$615 Hold
47
– – ﹤0.01% 3769
2025
Q1 		$487 Buy
+47
New +$571 ﹤0.01% 3512

Other funds holding ATOS

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jones Financial Companies's ATOS Position: Q2 2026 in Review

Jones Financial Companies held its Atossa Therapeutics (ATOS) position steady in Q2 2026 at 2,061 shares worth $3.88K. The position accounts for ﹤0.01% of the portfolio, ranked #4212.

Jones Financial Companies first reported a position in ATOS in Q1 2025 and has held it in 6 quarters since. The position peaked at $9.73K in Q1 2026. 31 funds tracked by Wall St. Rank hold ATOS as of Q2 2026.

  • Jones Financial Companies held 2,061 shares of Atossa Therapeutics worth $3.88K as of Q2 2026.
  • Jones Financial Companies left its Atossa Therapeutics share count unchanged in Q2 2026.
  • Atossa Therapeutics made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4212 holding.
  • Jones Financial Companies first reported a position in Atossa Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • Jones Financial Companies's Atossa Therapeutics position peaked at $9.73K in Q1 2026.
  • 31 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.